Brentuximab vedotin monotherapy is an effective treatment in a frail pediatric patient with Down syndrome and classical Hodgkin lymphoma

被引：1
|
作者：
Vonasek, Julia [1 ]
Edslev, Pernille Wendtland [1 ]
d'Amore, Francesco [2 ]
Hasle, Henrik [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Pediat & Adolescent Hlth, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷 / 02期
关键词：
D O I：
10.1002/pbc.28082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BRENTUXIMAB VEDOTIN IS EFFECTIVE IN HODGKIN LYMPHOMA
    不详
    CANCER DISCOVERY, 2012, 2 (05) : 385 - 385
  • [2] Treatment of relapsed classical Hodgkin lymphoma in the brentuximab vedotin era
    Graf, Solomon A.
    Gopal, Ajay K.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 151 - 157
  • [3] Desensitization of Brentuximab Vedotin in a Patient with Hodgkin Lymphoma
    Khalid, Sidra
    Khalid, Aariez
    Clark, Bernadette A.
    Daw, Hamed
    CUREUS, 2018, 10 (07):
  • [4] The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma
    Lai, Catherine
    Kandahari, Adrese Michael
    Ujjani, Chaitra
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2019, 9 : 63 - 71
  • [5] Update on the role of brentuximab vedotin in classical Hodgkin lymphoma
    Tomassetti, Sarah
    Herrera, Alex F.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (09) : 261 - 272
  • [6] Safe prolonged use of brentuximab vedotin in a patient with Classical Hodgkin Lymphoma on hemodialysis
    Schad, Aimee
    Pakanati, Abhinandan R.
    Woelich, Susan
    Chilkulwar, Abhishek
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2023, 11
  • [7] Brentuximab vedotin for the treatment of Hodgkin's lymphoma
    Anh Pham
    Chen, Robert
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 403 - 412
  • [8] Brentuximab Vedotin for the Treatment of Patients with Hodgkin Lymphoma
    Younes, Anas
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (01) : 27 - +
  • [9] Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors
    A. M. Carella
    P. Corradini
    A. Mussetti
    U. Ricardi
    U. Vitolo
    S. Viviani
    Annals of Hematology, 2018, 97 : 1301 - 1315
  • [10] Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors
    Carella, A. M.
    Corradini, P.
    Mussetti, A.
    Ricardi, U.
    Vitolo, U.
    Viviani, S.
    ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1301 - 1315
12345